Indivior Pharmaceuticals (INDV) Asset Writedowns and Impairment (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Asset Writedowns and Impairment of $6.0 million for Q1 2026, up 100.0% quarter-over-quarter from $3.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Asset Writedowns and Impairment (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at $6.0 million for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $25.0 million (up 257.14% YoY), while the FY2025 annual figure was $19.0 million, up 137.5% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $6.0 million, up from $3.0 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $16.0 million in Q3 2025, with the low at $1.0 million in Q1 2024.
- The 3-year median for Asset Writedowns and Impairment is $6.0 million (2026), against an average of $6.6 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.51 Bn | 4.29 Bn | 294.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Mn |
| Jun 30, 2026 | 2.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 16.00 Mn |
| Sep 30, 2025 | 16.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |